Skip to main content
Premium Trial:

Request an Annual Quote

Life Technologies, Bio-Rad to Join S&P Indexes

NEW YORK (GenomeWeb News) – Standard & Poor’s last night said that Life Technologies, the name of the combined Invitrogen and Applied Biosystems, will replace Applied Biosystems in the S&P 500 Index.
 
Invitrogen and ABI expect to close their $6.7 billion merger later this week, after which time they will operate under the Life Technologies name.
 
S&P also said that Bio-Rad Laboratories will replace Invitrogen in the S&P Mid-Cap 400. Both of the changes will take place after the close of the market on Friday.
 

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.